ES2057262T3 - Derivados del cromano. - Google Patents

Derivados del cromano.

Info

Publication number
ES2057262T3
ES2057262T3 ES90109529T ES90109529T ES2057262T3 ES 2057262 T3 ES2057262 T3 ES 2057262T3 ES 90109529 T ES90109529 T ES 90109529T ES 90109529 T ES90109529 T ES 90109529T ES 2057262 T3 ES2057262 T3 ES 2057262T3
Authority
ES
Spain
Prior art keywords
chroman
derivatives
formula
alopecia
incontinence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90109529T
Other languages
English (en)
Inventor
Rolf Dr Gericke
Manfred Dr Baumgarth
Ingeborg Dr Lues
Peyer Jacques Dr De
Rolf Dr Bergmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Application granted granted Critical
Publication of ES2057262T3 publication Critical patent/ES2057262T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

EL INVENTO CONCIERNE A LOS DERIVADOS DEL CROMANO DE FORMULA I (FORMULA), EN LA QUE R1 A R8 TIENE EL SIGNIFICADO DADO EN LA REIVINDICACION 1 DE LA PATENTE, LOS CUALES, AL IGUAL QUE SUS SALES, MUESTRAN ACTIVIDAD SOBRE EL SISTEMA CARDIOVASCULAR Y PUEDEN SER UTILIZADOS PARA EL TRATAMIENTO Y PROFILAXIS DE LA INSUFICIENCIA CARDIACA, ANGINA PECTORIS, TENSION ELEVADA DE SANGRE, INCONTINENCIA Y ALOPECIA.
ES90109529T 1989-06-02 1990-05-19 Derivados del cromano. Expired - Lifetime ES2057262T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3918041A DE3918041A1 (de) 1989-06-02 1989-06-02 Chromanderivate

Publications (1)

Publication Number Publication Date
ES2057262T3 true ES2057262T3 (es) 1994-10-16

Family

ID=6381944

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90109529T Expired - Lifetime ES2057262T3 (es) 1989-06-02 1990-05-19 Derivados del cromano.

Country Status (20)

Country Link
US (1) US5112972A (es)
EP (1) EP0400430B1 (es)
JP (1) JPH0320275A (es)
KR (1) KR910000713A (es)
AR (1) AR245715A1 (es)
AT (1) ATE110072T1 (es)
AU (1) AU623780B2 (es)
CA (1) CA2017961A1 (es)
DE (2) DE3918041A1 (es)
DK (1) DK0400430T3 (es)
ES (1) ES2057262T3 (es)
FI (1) FI95701C (es)
HU (1) HUT58323A (es)
IE (1) IE65098B1 (es)
IL (1) IL94256A (es)
NO (1) NO175976C (es)
NZ (1) NZ233912A (es)
PT (1) PT94225B (es)
TW (1) TW210338B (es)
ZA (1) ZA904227B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3835011A1 (de) * 1988-10-14 1990-04-19 Merck Patent Gmbh Chromanderivate
US5387587A (en) * 1986-12-23 1995-02-07 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
DE3837809A1 (de) * 1988-11-08 1990-05-10 Merck Patent Gmbh Tetralinderivate
DE3924417A1 (de) * 1989-07-24 1991-01-31 Merck Patent Gmbh Chromanderivate
JP3442815B2 (ja) * 1992-05-13 2003-09-02 第一製薬株式会社 ジアザビシクロアルケン誘導体
GB9316111D0 (en) * 1993-08-04 1993-09-22 Pfizer Ltd Benzopyrans
US5719155A (en) * 1993-11-10 1998-02-17 Japan Tobacco Inc. Chroman derivative and pharmaceutical use thereof
US5470861A (en) * 1994-08-04 1995-11-28 Hoffmann-La Roche Inc. Method of promoting hair growth
US6555574B1 (en) 1999-09-24 2003-04-29 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
EP1218367A1 (en) * 1999-10-05 2002-07-03 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
ES2311727T3 (es) 2002-11-12 2009-02-16 Warner-Lambert Company Llc Procedimiento de estimulacion del crecimiento del cabello usando benzopiranos.
AU2005316739A1 (en) * 2004-12-13 2006-06-22 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
CN101296731A (zh) 2005-09-01 2008-10-29 詹森药业有限公司 作为钾通道开启剂的苯并吡喃和吡喃并吡啶衍生物
WO2024040267A2 (en) * 2022-08-19 2024-02-22 Mitokinin, Inc. Direct synthesis of n-(3-substituted-chroman-4-yl)-7h- pyrrolo[2,3-d]pyrimidin-4-amines and derivatives thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0076075B1 (en) * 1981-09-25 1986-11-20 Beecham Group Plc Pharmaceutically active benzopyran compounds
DE3364145D1 (de) * 1982-04-08 1986-07-24 Beecham Group Plc Antihypertensive benzopyranols
EP0093534A1 (en) * 1982-04-28 1983-11-09 Beecham Group Plc Novel chromanols
GB8419516D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
GB8419515D0 (en) * 1984-07-31 1984-09-05 Beecham Group Plc Treatment
PT84806B (pt) * 1986-05-03 1989-12-29 Beecham Group Plc Processo para a preparacao de benzopiranos
DE3726261A1 (de) * 1986-12-23 1988-07-07 Merck Patent Gmbh Chromanderivate
FR2615191B1 (fr) * 1987-05-16 1991-01-11 Sandoz Sa Nouveaux benzo(b)pyrannes et pyrannopyridines, leur preparation et leur utilisation comme medicaments
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
AU628331B2 (en) * 1988-05-06 1992-09-17 Merck Patent Gesellschaft Mit Beschrankter Haftung Chroman derivatives
EP0346724A1 (de) * 1988-06-16 1989-12-20 MERCK PATENT GmbH Chromanderivate

Also Published As

Publication number Publication date
IE65098B1 (en) 1995-10-04
NO175976B (no) 1994-10-03
NO902459D0 (no) 1990-06-01
AR245715A1 (es) 1994-02-28
EP0400430B1 (de) 1994-08-17
AU5600790A (en) 1990-12-06
ATE110072T1 (de) 1994-09-15
TW210338B (es) 1993-08-01
IE901988A1 (en) 1991-01-02
PT94225B (pt) 1996-12-31
NO902459L (no) 1990-12-03
NO175976C (no) 1995-01-11
EP0400430A2 (de) 1990-12-05
FI902727A0 (fi) 1990-06-01
AU623780B2 (en) 1992-05-21
HUT58323A (en) 1992-02-28
FI95701C (fi) 1996-03-11
HU903293D0 (en) 1990-10-28
PT94225A (pt) 1991-02-08
IL94256A0 (en) 1991-03-10
FI95701B (fi) 1995-11-30
JPH0320275A (ja) 1991-01-29
NZ233912A (en) 1992-10-28
EP0400430A3 (de) 1991-01-02
DE3918041A1 (de) 1990-12-06
IE901988L (en) 1990-12-02
KR910000713A (ko) 1991-01-30
IL94256A (en) 1994-04-12
CA2017961A1 (en) 1990-12-02
DK0400430T3 (da) 1994-09-12
US5112972A (en) 1992-05-12
DE59006817D1 (de) 1994-09-22
ZA904227B (en) 1991-03-27

Similar Documents

Publication Publication Date Title
ES2057262T3 (es) Derivados del cromano.
ES2155134T3 (es) Derivados de imidazolidina y su utilizacion.
NO914092L (no) Nye mercaptoacetylamid-derivater som er anvendbare som inhibitorer for enkefalinase og ace
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
NO923744L (no) Nye 2-substituerte indan-2-mercaptoacetylamidderivater anvendbare som inhibitorer av enkefalinase og ace
ES2152222T3 (es) Sulfonamidas, su preparacion y su uso como medicamento e intermedio.
MX9305769A (es) Nuevos derivados de analogos del taxol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
ES2053778T3 (es) Procedimiento para la obtencion de derivados del tiazol.
NO912630L (no) Fremgangsmaate for fremstilling av nye 2,6-dialkyl-4-silyl-fenoler som antiarteriosklerotiske midler
ES2055406T3 (es) Composicion para el tratamiento de la inflamacion.
ES2058093T3 (es) Agentes herbicidas y fungicidas a base de derivados de pirazolin-5-ona substituidos.
DK0424028T3 (da) S(+)-ibuprofen-L-aminosyre og S(+)-ibuprofen-D-aminosyre som et forbedret smertestillende middel med fremskyndet indtrædelse
DK0773022T3 (da) Farmaceutisk sammensætning til behandling af rhinitis indeholdende sympathomimetika og pantothenol og/eller pantothensyre
ES2073483T3 (es) Derivados del cromano.
DE3860201D1 (de) Entzuendungshemmende agentien.
IT1212141B (it) Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
ES2045348T3 (es) Metodo para preparar derivados de lactamimida para el tratamiento o la prevencion de paludismo farmaco-resistente.
PT90743A (pt) Processo para a preparacao de derivados de hirudina com accao retardada e de composicoes farmaceuticas que os contem
DK605589D0 (da) Anvendelse af aminobenzocycloalkaner eller syreadditionssalte deraf til fremstilling af et farmaceutikum, saaledes fremstillet praeparat og dettes anvendelse
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
ES2119751T3 (es) Derivados del cromano.
PT86771A (pt) Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity
ATE148626T1 (de) Katecholderivate, deren physiologisch unbedenkliche salze, ester und deren verwendung bei der behandlung von durch lipidperoxidation verursachten gewebeschäden
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
ES2105815T3 (es) Nuevos derivados de hidrazino- e hidroxiamino-14beta-hidroxiandrostano activos sobre el sistema cardiovascular, procesos para su preparacion y composiciones farmaceuticas que contienen los mismos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 400430

Country of ref document: ES